Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,682,943
+$558,956 QoQ
Shares Held
51,065
+10.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#309
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 93%
Shared 1%
None 5%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pinnacle Financial Partners, Inc. holds $518,224,933 across 13 Drug Manufacturers - General names. AZN ranks #8 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
155,017 | $185,932,054 | |
| 2 | JNJ |
Johnson & Johnson
|
447,481 | $113,646,747 | |
| 3 | ABBV |
AbbVie Inc.
|
309,302 | $77,832,753 | |
| 4 | MRK |
Merck & Co., Inc.
|
324,931 | $41,753,633 | |
| 5 | AMGN |
Amgen Inc
|
107,659 | $38,985,475 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
298,653 | $17,208,384 | |
| 7 | PFE |
Pfizer Inc
|
697,936 | $16,806,297 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
51,065 | $9,682,943 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,682,943 | 51,065 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $9,123,987 | 46,263 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||